IL6 and ovarian cancer: IL-6 demonstrated strong diagnostic and prognostic potential, reaching an AUC of 1.000 in ovarian cancer when used alone or with VEGF-A [46] and was associated with poorer survival when elevated alongside TNF-α [30].